Evidence map›Paper›PMID 30219480›Full record

ArticleBone2018

Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model.

Niall J Logan, Marie Camman, Greg Williams, Claire A Higgins

Open access · hybridAbstract read
In one paragraph

Article in Bone, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Niall J LoganDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom,. Electronic address: n.logan@imperial.ac.uk.
Marie CammanDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom.
Greg WilliamsFarjo Hair Institute, London, W1G 7LH, United Kingdom. Electronic address: dr.greg@farjo.com.
Claire A HigginsDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom,. Electronic address: c.higgins@imperial.ac.uk.
Imperial College London · GBFarr Institute · GB

Funding

Medical Research Council M01858X/1Medical Research Council MR/M01858X/1
6 · The paper itself

Abstract

Trauma-induced heterotopic ossification is an intriguing phenomenon involving the inappropriate ossification of soft tissues within the body such as the muscle and ligaments. This inappropriate formation of bone is highly prevalent in those affected by blast injuries. Here, we developed a simplified cell culture model to evaluate the molecular events involved in heterotopic ossification onset that arise from the shock wave component of the disease. We exposed three subtypes of human mesenchymal cells in vitro to a single, high-energy shock wave and observed increased transcription in the osteogenic master regulators, Runx2 and Dlx5, and significantly accelerated cell mineralisation. Reduced representation bisulfite sequencing revealed that the shock wave altered methylation of gene promoters, leading to opposing changes in gene expression. Using a drug to target ITGAV, whose expression was perturbed by the shock wave, we found that we could abrogate the deposition of mineral in our model. These findings show how new therapeutics for the treatment of heterotopic ossification can be identified using cell culture models.

Indexed as

Cell DifferentiationDemethylationModels, BiologicalOsteogenesisBlast InjuriesCalcification, PhysiologicCell Culture TechniquesCell NucleusDNA MethylationHigh-Energy Shock WavesHumansIntegrin alphaVOssification, HeterotopicPromoter Regions, GeneticIntegrin alphaVBlast overpressure exposureEpigenetic DNA methylationHeterotopic ossificationIn vitro modelOssification

Identifiers

PMID30219480
PMCPMC6218666
OpenAlexW2891773538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.